A detailed history of Amalgamated Bank transactions in Immunovant, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,841 shares of IMVT stock, worth $50,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,841
Previous 1,841 -0.0%
Holding current value
$50,645
Previous $49,000 6.12%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$30.27 - $43.79 $180,621 - $261,294
-5,967 Reduced 76.42%
1,841 $59,000
Q4 2023

Feb 06, 2024

SELL
$31.31 - $44.19 $2,911 - $4,109
-93 Reduced 1.18%
7,808 $329,000
Q2 2023

Aug 11, 2023

BUY
$14.2 - $23.75 $45,738 - $76,498
3,221 Added 68.82%
7,901 $149,000
Q1 2023

May 02, 2023

SELL
$15.27 - $19.72 $17,774 - $22,954
-1,164 Reduced 19.92%
4,680 $73,000
Q4 2022

Feb 10, 2023

BUY
$6.59 - $17.75 $5,034 - $13,561
764 Added 15.04%
5,844 $104,000
Q2 2022

Aug 15, 2022

SELL
$3.38 - $5.65 $2,916 - $4,875
-863 Reduced 14.52%
5,080 $20,000
Q1 2022

Jun 30, 2022

BUY
$5.06 - $8.77 $30,071 - $52,120
5,943 New
5,943 $33,000
Q1 2021

May 13, 2021

SELL
$13.08 - $49.6 $76,400 - $289,713
-5,841 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$36.36 - $52.71 $212,378 - $307,879
5,841 New
5,841 $269,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.